Eiji Oki

18.6k total citations
617 papers, 10.9k citations indexed

About

Eiji Oki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eiji Oki has authored 617 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 326 papers in Oncology, 255 papers in Pulmonary and Respiratory Medicine and 220 papers in Surgery. Recurrent topics in Eiji Oki's work include Gastric Cancer Management and Outcomes (175 papers), Colorectal Cancer Treatments and Studies (167 papers) and Genetic factors in colorectal cancer (99 papers). Eiji Oki is often cited by papers focused on Gastric Cancer Management and Outcomes (175 papers), Colorectal Cancer Treatments and Studies (167 papers) and Genetic factors in colorectal cancer (99 papers). Eiji Oki collaborates with scholars based in Japan, United States and Taiwan. Eiji Oki's co-authors include Yoshihiko Maehara, Yoshihiro Kakeji, Masaru Morita, Eriko Tokunaga, Hiroshi Saeki, Koji Ando, Hideo Baba, Hiroshi Saeki, Yuichiro Nakashima and Akinori Egashira and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eiji Oki

564 papers receiving 10.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eiji Oki 4.5k 3.5k 3.5k 3.3k 1.8k 617 10.9k
Se Jin Jang 3.2k 0.7× 3.0k 0.8× 3.9k 1.1× 1.9k 0.6× 1.4k 0.8× 277 9.2k
Yoshiharu Sakai 5.4k 1.2× 3.2k 0.9× 3.0k 0.9× 4.1k 1.2× 1.6k 0.9× 409 11.8k
Koji Tanaka 3.7k 0.8× 3.6k 1.0× 2.9k 0.8× 3.5k 1.1× 2.7k 1.5× 471 10.9k
Wolff Schmiegel 6.2k 1.4× 4.1k 1.2× 2.3k 0.6× 3.4k 1.0× 2.2k 1.3× 267 13.1k
Yoshifumi Baba 5.6k 1.2× 4.6k 1.3× 3.2k 0.9× 4.2k 1.3× 2.6k 1.5× 360 12.9k
Kosei Hirakawa 7.6k 1.7× 4.6k 1.3× 3.3k 0.9× 3.2k 1.0× 3.2k 1.8× 590 14.2k
Arndt Vogel 4.5k 1.0× 3.0k 0.9× 3.1k 0.9× 4.1k 1.2× 1.9k 1.1× 384 12.9k
Ken Kato 5.1k 1.1× 3.2k 0.9× 5.7k 1.6× 6.2k 1.9× 1.6k 0.9× 507 13.3k
Yoshihiro Kakeji 5.3k 1.2× 3.8k 1.1× 6.3k 1.8× 6.1k 1.8× 1.8k 1.0× 699 14.9k
Masaki Mori 5.7k 1.3× 2.3k 0.7× 3.1k 0.9× 4.0k 1.2× 1.2k 0.7× 445 10.3k

Countries citing papers authored by Eiji Oki

Since Specialization
Citations

This map shows the geographic impact of Eiji Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Oki more than expected).

Fields of papers citing papers by Eiji Oki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Oki. The network helps show where Eiji Oki may publish in the future.

Co-authorship network of co-authors of Eiji Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Oki. A scholar is included among the top collaborators of Eiji Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Oki. Eiji Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohashi, Kenichi, Taisuke Sasaki, Eikichi Ihara, et al.. (2024). Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma. Gastric Cancer. 27(3). 484–494. 5 indexed citations
2.
Oki, Eiji, Ryota Nakanishi, Koji Ando, et al.. (2024). Recurrence monitoring using ctDNA in patients with metastatic colorectal cancer: COSMOS-CRC-03 and AURORA studies. SHILAP Revista de lepidopterología. 3. 100034–100034. 1 indexed citations
3.
Nakamura, Yoshiaki, Kristiyana Kaneva, Christine Lo, et al.. (2024). Longitudinal clinical performance of a novel tumor-naive minimal residual disease assay in patients with resected stage II and III colorectal cancer: A subset analysis from the GALAXY study in CIRCULATE-Japan.. Journal of Clinical Oncology. 42(16_suppl). 3618–3618. 2 indexed citations
4.
Kagawa, Yoshinori, Jun Watanabe, Koji Ando, et al.. (2024). Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.. Journal of Clinical Oncology. 42(23_suppl). 71–71.
5.
Shinto, Eiji, Eiji Oki, Mototsugu Shimokawa, et al.. (2023). Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients. Annals of Surgical Oncology. 30(8). 5239–5247. 2 indexed citations
6.
Kagawa, Yoshinori, Jun Watanabe, Mamoru Uemura, et al.. (2023). Short‐term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE‐1). Annals of Gastroenterological Surgery. 7(6). 968–976. 5 indexed citations
7.
Yuki, Satoshi, Takeshi Kawakami, Takatsugu Ogata, et al.. (2023). 615P The impacts of starting regorafenib dose on treatment outcomes in metastatic colorectal cancer. Annals of Oncology. 34. S441–S442. 1 indexed citations
8.
Ebihara, Yuma, Satoshi Hirano, Takahiro Kanno, et al.. (2023). Technical evaluation of robotic tele-cholecystectomy: a randomized single-blind controlled pilot study. Journal of Robotic Surgery. 17(3). 1105–1111. 5 indexed citations
9.
Ikeda, Tetsuo, Shinji Okano, Shotaro Korehisa, et al.. (2022). Three‐dimensional imaging of intramural perineural invasion in colorectal cancer: Three‐dimensional reconstruction approach with multiple immunohistochemically stained sections. Pathology International. 72(5). 293–299. 4 indexed citations
10.
Kawazoe, Tetsuro, Hiroshi Saeki, Eiji Oki, et al.. (2020). Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation. Molecular Cancer Research. 18(12). 1876–1888. 6 indexed citations
11.
Nakanishi, Ryota, Tomoko Jogo, Yuichiro Nakashima, et al.. (2018). Gastric Cancer of "Crawling Type" Detected by Additional Gastrectomy After Endoscopic Submucosal Resection. Anticancer Research. 38(4). 2335–2338. 2 indexed citations
12.
Yang, Shenghong, Yu Imamura, Russell W. Jenkins, et al.. (2016). Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation. Cancer Immunology Research. 4(6). 520–530. 76 indexed citations
13.
Kasagi, Yuta, Yui Harada, Yosuke Morodomi, et al.. (2016). Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix–Directed Spheroid Formation. Cancer Research. 76(2). 347–357. 26 indexed citations
14.
Hayashi, Hiromitsu, Takaaki Higashi, Naomi Yokoyama, et al.. (2015). An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression. Cancer Research. 75(22). 4985–4997. 121 indexed citations
15.
Kiyonari, Shinichi, Makoto Iimori, Kazuaki Matsuoka, et al.. (2015). The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. Molecular Cancer Therapeutics. 14(10). 2332–2342. 26 indexed citations
16.
Ida, Satoshi, Nobuyuki Ozaki, Kimi Araki, et al.. (2015). SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer. Molecular Cancer Research. 13(7). 1130–1138. 29 indexed citations
17.
Matsuoka, Kazuaki, Makoto Iimori, Hiroshi Tsukihara, et al.. (2015). Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand Breaks. Molecular Cancer Therapeutics. 14(4). 1004–1013. 50 indexed citations
18.
Baba, Yoshifumi, Masayuki Watanabe, Asuka Murata, et al.. (2014). LINE-1 Hypomethylation, DNA Copy Number Alterations, and CDK6 Amplification in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 20(5). 1114–1124. 61 indexed citations
19.
Sawayama, Hiroshi, Takatsugu Ishimoto, Masayuki Watanabe, et al.. (2013). Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer. Cancer Research. 74(2). 575–585. 51 indexed citations
20.
Yotsumoto, Fusanori, Eriko Tokunaga, Eiji Oki, et al.. (2013). Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer. Molecular Cancer Research. 11(5). 506–517. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026